Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2025 Earnings Call Transcript May 8, 2025
Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.03.
Operator: Good day and thank you for standing by. Welcome to Akebia’s First Quarter 2025 Financial Results Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be question-and-answer session. [Operator Instructions] Please be advised that today’s...
